These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11329045)

  • 1. Inflammation and Alzheimer disease: the good, the bad, and the ugly.
    Weninger SC; Yankner BA
    Nat Med; 2001 May; 7(5):527-8. PubMed ID: 11329045
    [No Abstract]   [Full Text] [Related]  

  • 2. Bringing amyloid into focus.
    Golde TE; Bacskai BJ
    Nat Biotechnol; 2005 May; 23(5):552-4. PubMed ID: 15877070
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation takes on Alzheimer disease.
    Golde TE
    Nat Med; 2002 Sep; 8(9):936-8. PubMed ID: 12205453
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.
    Hintersteiner M; Enz A; Frey P; Jaton AL; Kinzy W; Kneuer R; Neumann U; Rudin M; Staufenbiel M; Stoeckli M; Wiederhold KH; Gremlich HU
    Nat Biotechnol; 2005 May; 23(5):577-83. PubMed ID: 15834405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
    Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C; Hosokawa M; McGeer PL
    Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.
    McGeer EG; McGeer PL
    Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
    Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary characterization of long-term reaggregating cultures of trisomy 16 central nervous system.
    Bredesen DE; Kane DJ; Holtzman DM; Epstein CJ
    Prog Clin Biol Res; 1992; 379():259-70. PubMed ID: 1409749
    [No Abstract]   [Full Text] [Related]  

  • 15. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
    Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta predictor of Alzheimer disease symptoms.
    Sephton CF; Yu G
    Arch Neurol; 2008 Jul; 65(7):875-6. PubMed ID: 18625853
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
    Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.